 |
| Nathan Rich |
Elevance Health, the big Indianapolis-based healthcare insurer formerly known as Anthem, has hired Nathan Rich as VP-investor relations, effective Nov. 11.
He succeeds Stephen Tanal, who is now CFO for Elevance’s government health benefits unit.
Rich joins Elevance from Goldman Sachs, where he served as a VP in its global investment research operation during a 12-year run.
He also spent seven years as a sell-side research analyst at Citibank, and was a financial planning analyst at Ameriprise Financial Services for two years.
At Elevance, Rich reports to Mark Kaye, EVP & CFO. He cited Rich's extensive experience in the managed care, healthcare services and consumer sector.
“His diverse expertise, coupled with his analytical acumen will be instrumental in driving our strategy forward as we continue to evolve as a lifetime trusted health partner,” said Kaye.
Elevance chalked up a 5.3 percent hike in Q3 revenues to $44.7B. Net income slid 22.5 percent to $1B due to “unprecedented challenges in the Medicaid business,” according to CEO Gail Boudreaux.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
In a recent conversation about the evolving media landscape, Doug Simon, CEO of D S Simon Media, spoke with Campbell O’Connor, Group Director, Media & Engagement at Real Chemistry, about how AI is influencing media relations and healthcare communications.
